Did the toxicant perturb ER proteostasis enough to engage UPR signaling?
The unfolded protein response as a proteotoxic stress-resolution circuit
A framework in which environmental toxicants act as proteotoxic inputs, IRE1α, PERK and ATF6 decode ER stress into immune outcomes, and failed resolution can shift immune and barrier cells toward persistent dysfunction.
The key question is not only whether a toxicant activates the UPR, but whether the response resolves once the exposure passes, or stays engaged and branch-skewed.
Every figure, explorer and simulation on this page is a conceptual illustration of the review's framework, not an experimental measurement. The framework is offered as a hypothesis-generating structure, and the causal step linking failed resolution to immune dysfunction remains largely extrapolated from non-toxicological ER-stress models.
Three questions define proteotoxic stress resolution
Which combination of IRE1α, PERK and ATF6 is engaged, and in which cell?
Did ER proteostasis and immune function return toward baseline before the next exposure?
How does the UPR turn toxicant exposure into an immune outcome?
What is already known, and what this review adds.
Three ER sensors read protein-folding stress
IRE1α, PERK and ATF6 sit in the endoplasmic reticulum membrane. When unfolded proteins accumulate, they signal through distinct but interacting programs that together make up the unfolded protein response (UPR).
Immune cells live near their ER folding limit
Cytokine secretion, antibody production and antigen presentation place a heavy folding load on the ER. That makes immune and barrier cells unusually dependent on ER quality control, so the same proteotoxic stress can reshape their function before any cell death.
Toxicants activate the UPR, and the UPR shapes immunity
That individual environmental toxicants activate ER-stress markers is established, most robustly for particulate matter. That UPR signaling influences inflammation, antigen presentation and secretion is also established. Neither observation is claimed as novel here.
Judge the outcome by how the signal resolves, not only whether it starts
The review proposes a branch-selective proteotoxic stress-resolution circuit: toxicants are proteotoxic inputs, IRE1α/PERK/ATF6 decode them into immune outputs, and failed resolution is one route by which exposure shifts immune cells toward persistent dysfunction.
Read further: the published proteotoxic stress-resolution review.
Interactive 3D model
Follow one immune cell as a toxicant perturbs its endoplasmic reticulum, the three UPR branches decode the stress, and the response either resolves or fails. Switch to the ER close-up to see IRE1α, PERK and ATF6 at the membrane. Drag to rotate.
A conceptual 3D model of an immune cell and its ER appears here in supporting browsers. The same content is described in the sections below.
Toxicant IRE1α PERK ATF6 Misfolded protein
Three non-interchangeable UPR branches
IRE1α, PERK and ATF6 are distinct modules that decode ER stress into different immune-relevant outputs. Select a branch to see its role and outputs.
Six toxicant classes, graded by evidence
Toxicants should not be treated as interchangeable ER stressors. Select a class to see its proteotoxic signature and the strength of evidence for UPR engagement, immune outcome and resolution.
Grades denote the directness and consistency of the available evidence, not the magnitude or toxicological importance of the effect. Strong: branch-resolved or perturbation evidence in exposure-relevant models. Moderate: consistent marker-level evidence or one well-controlled model. Limited: few studies, indirect readouts or non-immune systems. Sparse: no direct evidence.
The same branches, different immune meaning per cell
IRE1α, PERK and ATF6 generate distinct outputs depending on cell type and stress context. Select a cell type to decode its dominant immune consequence.
Adaptive resolution versus failed resolution
Resolution is an active restoration process, not a passive decline. The outcome depends on stress duration, branch dynamics and whether ER proteostasis is restored.
Adaptive resolution
UPR signaling is transient and resolves, returning immune function toward baseline.
- ERAD, proteasomal clearance, autophagy and ER-phagy remove misfolded proteins and excess stress-expanded ER
- Ca²⁺ and redox balance normalize; translation recovers through GADD34-mediated eIF2α dephosphorylation
- IRE1α-XBP1 restores secretory capacity in high-demand cells
- Cytokine secretion, antigen presentation, antibody secretion and barrier function are restored
Failed resolution
Unfolded-protein burden persists and drives sustained or branch-skewed signaling.
- Persistent or excessive IRE1α signaling through RIDD, XBP1s and TRAF2–ASK1-JNK / NF-κB
- Prolonged PERK-ISR signaling suppresses cytokine protein synthesis; premature recovery reimposes ER burden
- Persistent cytokine signaling, impaired antigen presentation, secretory collapse
- Immunosuppressive function, T-cell dysfunction, epithelial barrier disruption and apoptosis
What happens across repeated low-dose exposures?
The framework predicts that incomplete recovery between pulses, not total dose, shifts cells toward altered setpoints. Adjust the pulse pattern and recovery capacity to see the effect.
Recovery keeps pace with exposure
Each pulse resolves before the next arrives, so the baseline setpoint is preserved.
Distinct failures converge on persistent dysfunction
Different disruptions within the resolution architecture produce recognizable failure modes. Select one to see the basis and its effect on immune dynamics.
Activation, resolution and function must all be read
Activation markers alone cannot distinguish transient adaptive stress from persistent immunotoxic signaling. The framework asks for all three layers, time-resolved.
Activation markers
- XBP1s
- Phospho-IRE1α
- Phospho-eIF2α
- ATF4
- CHOP
- Cleaved ATF6
- BiP / GRP78
Resolution markers
- Return-to-baseline time
- Signal half-life
- ERAD markers
- ER-phagy markers
- Autophagic flux
- Protein-synthesis recovery
- Ca²⁺ / redox normalization
- Secretory restoration
Functional immune outputs
- Cytokine secretion
- Antigen presentation
- Antibody secretion
- T-cell effector function
- Epithelial barrier function
- Viability
Four priority experiments
Not all predictions are equally tractable. Four define the most immediate agenda, and across all of them the common requirement is to report the recovery phase and the branch, not only the peak and the marker.
Measure recovery kinetics directly
Sample after exposure withdrawal, not only during it. Report the recovery half-time of each branch and the inter-exposure interval below which recovery becomes incomplete, together with the fraction that fails to return.
Repeated low-dose vs dose-matched single exposure
Hold cumulative dose constant and vary the interval between pulses relative to the measured recovery half-time, so incomplete recovery rather than total dose becomes the manipulated variable.
Mixed exposures by sensing mechanism
Pair a membrane-perturbing toxicant with a misfolding-inducing one, since IRE1 senses bilayer stress while ATF6 responds to luminal and sphingolipid inputs. Test whether co-exposure extends the recovery period disproportionately.
Map cell-type vulnerability
Profile exposed tissue at single-cell resolution with paired functional output, to identify which high-secretory or barrier populations fail first and whether failure tracks secretory load, branch bias or resolution capacity.
What is observed, extrapolated, or predicted?
The framework's three central claims rest on different bodies of research. Switch between them to keep direct observation apart from inference.